BRPI0924525A2 - "derivativos de colestanol para uso combinado" - Google Patents

"derivativos de colestanol para uso combinado"

Info

Publication number
BRPI0924525A2
BRPI0924525A2 BRPI0924525A BRPI0924525A BRPI0924525A2 BR PI0924525 A2 BRPI0924525 A2 BR PI0924525A2 BR PI0924525 A BRPI0924525 A BR PI0924525A BR PI0924525 A BRPI0924525 A BR PI0924525A BR PI0924525 A2 BRPI0924525 A2 BR PI0924525A2
Authority
BR
Brazil
Prior art keywords
combined use
cholestanol derivatives
cholestanol
derivatives
combined
Prior art date
Application number
BRPI0924525A
Other languages
English (en)
Inventor
Shin Yazawa
Takayuki Asao
Toyo Nishimura
Original Assignee
Univ Gunma Nat Univ Corp
Otsuka Pharmaceutica Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gunma Nat Univ Corp, Otsuka Pharmaceutica Co Ltd filed Critical Univ Gunma Nat Univ Corp
Priority claimed from PCT/JP2009/004353 external-priority patent/WO2010100686A1/ja
Publication of BRPI0924525A2 publication Critical patent/BRPI0924525A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0924525A 2008-03-05 2009-09-03 "derivativos de colestanol para uso combinado" BRPI0924525A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008055284 2008-03-05
PCT/JP2009/000985 WO2009110235A1 (ja) 2008-03-05 2009-03-04 コレスタノール誘導体の併用用途
PCT/JP2009/004353 WO2010100686A1 (ja) 2009-03-04 2009-09-03 コレスタノール誘導体の併用用途

Publications (1)

Publication Number Publication Date
BRPI0924525A2 true BRPI0924525A2 (pt) 2016-03-01

Family

ID=41055800

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0908756-7A BRPI0908756A2 (pt) 2008-03-05 2009-03-04 Uso combinado de derivado do colestanol
BRPI0924525A BRPI0924525A2 (pt) 2008-03-05 2009-09-03 "derivativos de colestanol para uso combinado"

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0908756-7A BRPI0908756A2 (pt) 2008-03-05 2009-03-04 Uso combinado de derivado do colestanol

Country Status (26)

Country Link
US (6) US8088744B2 (pt)
EP (1) EP2251014B8 (pt)
JP (1) JP5336466B2 (pt)
KR (1) KR20100120674A (pt)
CN (2) CN101678037B (pt)
AR (1) AR070857A1 (pt)
AU (1) AU2009220699C1 (pt)
BR (2) BRPI0908756A2 (pt)
CA (1) CA2717135A1 (pt)
CO (2) CO6311080A2 (pt)
CY (1) CY1115217T1 (pt)
DK (1) DK2251014T3 (pt)
ES (1) ES2437640T3 (pt)
HR (2) HRP20140154T1 (pt)
IL (1) IL207874A (pt)
MX (1) MX2010009794A (pt)
NZ (2) NZ587729A (pt)
PL (1) PL2251014T3 (pt)
PT (1) PT2251014E (pt)
RU (1) RU2492865C2 (pt)
SG (2) SG188805A1 (pt)
SI (1) SI2251014T1 (pt)
TW (1) TWI492759B (pt)
UA (2) UA101831C2 (pt)
WO (1) WO2009110235A1 (pt)
ZA (1) ZA201006228B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5032849B2 (ja) * 2004-01-14 2012-09-26 ギリアード サイエンシーズ， インコーポレイテッド 薬物送達に有用な脂質ベースの分散物
JP5480241B2 (ja) * 2009-03-04 2014-04-23 大塚製薬株式会社 コレスタノール誘導体の併用用途
PT2404608E (pt) * 2009-03-04 2015-07-21 Otsuka Pharma Co Ltd Derivado de colestanol para utilização combinada
WO2013179310A1 (en) * 2012-05-31 2013-12-05 Mylan Laboratories Limited Stable aqueous compositions of pemetrexed
CN119855598A (zh) * 2022-07-20 2025-04-18 约翰内斯堡威特沃特斯兰德大学 作为癌症疗法新辅助剂或辅助剂的2-羟丙基-β-环糊精

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5782310A (en) 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation
JPS6012127A (ja) 1983-06-30 1985-01-22 Dai Ichi Seiyaku Co Ltd リポソ−ムの製法
JPS6058915A (ja) 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
JPH0610131B2 (ja) 1987-10-30 1994-02-09 テルモ株式会社 リポソームの製法
JPH01167218A (ja) 1987-12-22 1989-06-30 Sumitomo Electric Ind Ltd 超電導薄膜の作製方法
JPH082780B2 (ja) 1990-05-28 1996-01-17 テルモ株式会社 リポソームの製法
JP3831958B2 (ja) 1995-09-20 2006-10-11 日本油脂株式会社 リポソーム用混合脂質及びリポソーム分散液
JP4105258B2 (ja) 1997-08-19 2008-06-25 大塚製薬株式会社 コレスタノール化合物及びこれを含有する医薬
JP4351314B2 (ja) 1998-12-24 2009-10-28 大塚製薬株式会社 コレスタノール化合物及びこれを含有する医薬
EE200200565A (et) * 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi
CN1822844B (zh) * 2003-07-17 2012-05-09 大塚制药株式会社 含配糖物的脂质体
CN1889943A (zh) * 2003-12-08 2007-01-03 美国亚利桑那大学董事会 协同抗癌组合物
PL1753512T3 (pl) * 2004-05-28 2009-03-31 4Sc Ag Tetrahydropirydotiofeny
TWI373473B (en) * 2005-09-02 2012-10-01 Otsuka Pharma Co Ltd Anticancer agent

Also Published As

Publication number Publication date
US20100062053A1 (en) 2010-03-11
CO6311080A2 (es) 2011-08-22
PT2251014E (pt) 2014-02-14
CY1115217T1 (el) 2017-01-04
RU2010140611A (ru) 2012-04-10
CN101678037A (zh) 2010-03-24
CN101678037B (zh) 2012-07-25
TWI492759B (zh) 2015-07-21
CO6361931A2 (es) 2012-01-20
US20140178464A1 (en) 2014-06-26
ES2437640T3 (es) 2014-01-13
BRPI0908756A2 (pt) 2015-07-21
SG188805A1 (en) 2013-04-30
EP2251014B1 (en) 2013-11-20
AR070857A1 (es) 2010-05-12
AU2009220699A1 (en) 2009-09-11
EP2251014A1 (en) 2010-11-17
US20130101679A1 (en) 2013-04-25
UA101831C2 (uk) 2013-05-13
JPWO2009110235A1 (ja) 2011-07-14
KR20100120674A (ko) 2010-11-16
EP2251014A4 (en) 2012-05-23
HK1145455A1 (en) 2011-04-21
US8088744B2 (en) 2012-01-03
AU2009220699B2 (en) 2013-06-20
TW200940097A (en) 2009-10-01
UA101884C2 (uk) 2013-05-13
SI2251014T1 (sl) 2014-02-28
NZ595615A (en) 2013-06-28
US20150374730A1 (en) 2015-12-31
CA2717135A1 (en) 2009-09-11
IL207874A (en) 2014-05-28
ZA201006228B (en) 2011-11-30
MX2010009794A (es) 2010-12-21
DK2251014T3 (da) 2013-12-02
HRP20140154T1 (hr) 2014-03-14
EP2251014B8 (en) 2014-01-08
HRP20150418T1 (hr) 2015-05-08
NZ587729A (en) 2012-03-30
US20120015025A1 (en) 2012-01-19
CN101969961A (zh) 2011-02-09
JP5336466B2 (ja) 2013-11-06
SG10201400171PA (en) 2014-06-27
RU2492865C2 (ru) 2013-09-20
US20120009251A1 (en) 2012-01-12
AU2009220699C1 (en) 2014-01-16
PL2251014T3 (pl) 2014-04-30
CN101969961B (zh) 2013-01-16
IL207874A0 (en) 2010-12-30
WO2009110235A1 (ja) 2009-09-11

Similar Documents

Publication Publication Date Title
BRPI0821668A2 (pt) Uso
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BRPI0818459A2 (pt) Composição farmacêutica adequada para uso oftálmico.
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BRPI0720993A2 (pt) métodos de uso para análogos de ciclopamina
BRPI0818079A2 (pt) composição de lipideo
SMT201500218B (it) Composti aril-fenil-solfonammido-cicloalchile e loro uso
BRPI0907563A2 (pt) Derivados de 4,5-di-hidro-xazol-2-il amina
ITMI20080003A1 (it) Composizioni per uso oftalmico
BRPI0909854A2 (pt) "arranjo de fracionamento"
CO6210802A2 (es) Composicion de locion para uso personal
PT1978981E (pt) Composições para uso vaginal
BRPI0917360A2 (pt) uso de d-ribose para indivíduos cansados
BRPI0914393A2 (pt) "método para caracterização de fitoquímicos"
BRPI0915905A2 (pt) uso de derivados de pirimidilaminobenzamida para o tratamento de fibrose
BRPI0909840A2 (pt) Uso de 4-tio-2-deoxinucleosídios
BRPI0908756A2 (pt) Uso combinado de derivado do colestanol
BRPI0814897A2 (pt) Ímãs termicamente estabilizados para uso em fundo de poço.
BRPI0815913A2 (pt) Composição de misturas antioxidantes apropriadas para uso em biodiesel.
BRPI0813662A2 (pt) Composição vacinal, processos para a obtenção da forma sanitária da composição vacinal e para a obtenção da composição vacinal, e, uso da composição vacinal
BRPI0807603A2 (pt) Composição depilatóra
ES1065835Y (es) Caperuza para cetreria
ES1065717Y (es) Envase plegable para uso domestico

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]